Description

History / Background

CJC-1295 is a synthetic peptide that mimics the action of Growth Hormone–Releasing Hormone (GHRH). Its primary function is to stimulate the pituitary gland to increase the secretion of growth hormone (GH). The “No DAC” version refers to CJC-1295 without the Drug Affinity Complex (DAC)—a modification designed to dramatically extend the peptide’s half-life.
Without DAC, the peptide has a shorter duration of action, often requiring more frequent dosing.

CJC-1295 (No DAC) has become popular in bodybuilding, performance enhancement, and wellness communities due to its potential to improve muscle growth, support recovery, and assist in fat loss. While research shows that it can elevate growth hormone levels, large-scale clinical trials evaluating its long-term safety and efficacy remain limited.

Benefits

Potential benefits of CJC-1295 (No DAC) include:

1. Increased Growth Hormone Levels
   By stimulating the pituitary gland, CJC-1295 increases endogenous GH production, which may support muscle growth and recovery.

2. Muscle Growth & Repair
   Higher GH levels promote protein synthesis and tissue repair, making the peptide appealing to athletes and bodybuilders.

3. Fat Loss
   Growth hormone plays a role in fat metabolism, and elevated GH may help reduce body fat while maintaining lean mass.

4. Improved Recovery
   Users often report faster recovery between workouts due to GH’s regenerative effects on muscle and connective tissue.

5. Potential Anti-Aging Properties
   Although still under investigation, GH elevation is sometimes associated with improvements in vitality, skin elasticity, and overall wellness.

Recommended Dosage

CJC-1295 (No DAC) is primarily used in research settings and lacks officially approved dosage guidelines. However, common anecdotal dosing practices include:

• Administration:
  Typically delivered via subcutaneous injection.

• Common Experimental Dosages:

  • 100–300 mcg per injection

  • Often administered 1–3 times per week, depending on goals and tolerance
    Some users combine CJC-1295 (No DAC) with GHRP peptides to amplify GH release, though this remains unregulated and purely anecdotal.

Important Considerations

• Regulatory Status
  CJC-1295 (No DAC) is not FDA-approved and is classified as a research chemical. Its long-term safety has not been validated through large clinical trials.

• Source & Purity
  Product quality varies widely. Many peptides are unregulated, making purity and accuracy of dosing inconsistent.

• Side Effects
  Possible side effects may include:

  • Injection site irritation

  • Water retention

  • Increased appetite

  • Fatigue

  • Potential hormonal fluctuations
    Long-term effects remain unclear due to limited human research.

• Healthcare Consultation
  Given its experimental nature, individuals considering use should consult a licensed healthcare professional to understand risks and interactions.